A complete application in a minute
Tailored resume and cover letter, ready to send.
ALX Oncology Inc. is seeking a CMC Planner to manage clinical supply chain transactions and shipping for ongoing trials at our South San Francisco office. You will coordinate CTM/IP shipments, oversee CMOs and vendors, and ensure GMP/GDP-aligned processes across labeling, packaging, and distribution.
This role emphasizes collaboration with Clinical Operations, QA, and Regulatory Affairs, with a hybrid onsite schedule. Preference is given to candidates who can work onsite Mondays and Tuesdays.
Reporting to the Manager, Clinical Supply Chain, the CMC Planner is responsible for managing, planning, executing, and following up on clinical supply chain transactions and shipping for ongoing ALX Oncology (ALX) clinical trials. The CMC Planner will work closely with internal teams, ALX Clinical Operations, and external partners to ensure the seamless flow of Clinical Trial Materials (CTM), including Investigational Products (IP), companion drugs, inventory tracking, and distribution logistics. This position plays a critical role in supporting the clinical development pipeline, ensuring that products are available at the right time and place, with the required quality and compliance.
Preference will be given to applicants who can regularly work onsite Mondays and Tuesdays as part of the company's hybrid work model. Applicants must be authorized to work in the United States without current or future employer sponsorship (e.g., H-1B sponsorship).
Key Responsibilities Include:
Preferred Qualifications Include:
Compensation
The salary range for this position at our South San Francisco, CA corporate office is $100,000 - $110,000. Additional factors such as academic credentials and relevant experience will influence the actual salary offered.In addition to a competitive market-based salary, ALX Oncology offers the opportunity to participate in stock programs, a performance-based bonus, and a comprehensive benefits package including 401K. Additional information can be found here: https://alxoncology.com/careers/
About ALX Oncology
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology’s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action. A Phase 1, dose-escalation trial of ALX2004 is ongoing in patients with EGFR-expressing solid tumors. More information is available at www.alxoncology.com and on LinkedIn @ ALX Oncology .
Information for Recruitment Agencies
Please note that ALX Oncology does not accept unsolicited resumes or candidate information from recruitment agencies, including blinded or anonymized resumes, and will not be responsible for any fees associated with unsolicited submissions. Do not contact hiring managers or other ALX Oncology employees directly.Recruiting activities are managed through our Human Resources team.